FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092333630> ?p ?o ?g. }

• W2092333630 endingPage "377" @default.
• W2092333630 startingPage "370" @default.
• W2092333630 abstract "A previous study indicated that pretreatment with repeated daily injections of serotonin-3 (5-HT3) receptor antagonists subsequently reduced the effectiveness of the 5-HT3 antagonists to attenuate ethanol intake under 24-h free-choice conditions; one possibility to account for this is that the functional activity of the 5-HT3 receptor may have been altered by prior treatment with the antagonists. The present experiments were conducted to examine the effects of local perfusion of the 5-HT3 agonist 1-(m-chlorophenyl)-biguanide (CPBG) on the extracellular levels of dopamine (DA) in the nucleus accumbens (ACB) and ventral tegmental area (VTA) of adult male Wistar rats that had received repeated daily injections of the 5-HT3 antagonist, MDL 72222 (MDL). In vivo microdialysis was used to test the hypothesis that alterations in 5-HT3 receptor function have occurred with repeated antagonist injections. One group was given daily injections of MDL (1 mg/kg, s.c.) for 10 consecutive days (MDL group), and the other group was administered saline for 10 days (saline group). On the day after the last treatment, rats were implanted with a unilateral guide cannula aimed at either the ACB or VTA. Two days later, the microdialysis probe was inserted into the guide cannula; on the next day, microdialysis experiments were conducted to determine the extracellular levels of DA in the ACB or VTA. Local perfusion of CPBG (17.5, 35, 70 μM) in the ACB significantly stimulated DA release in the saline- and MDL-treated animals. In terms of percent baseline, the CPBG-stimulated DA release was higher in the MDL-treated group than in the saline-treated group in both the ACB and VTA; however, on the basis of the extracellular concentration, there were no significant differences in the ACB between the two groups. Using the no-net-flux microdialysis, it was determine that the basal extracellular concentration of DA in the ACB was approximately 60% lower in the MDL group than saline group; there was no difference between the groups in the extraction fraction (clearance). Overall, the results suggest that repeated daily treatments with MDL decreased basal DA neurotransmission in the ACB and did not have a clear effect on functional activity of 5-HT3 receptors in the ACB." @default.
• W2092333630 created "2016-06-24" @default.
• W2092333630 creator A5010653984 @default.
• W2092333630 creator A5036789705 @default.
• W2092333630 creator A5088427667 @default.
• W2092333630 date "2006-06-01" @default.
• W2092333630 modified "2023-09-27" @default.
• W2092333630 title "Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats" @default.
• W2092333630 cites W1969181676 @default.
• W2092333630 cites W1971018774 @default.
• W2092333630 cites W1971410298 @default.
• W2092333630 cites W1972232167 @default.
• W2092333630 cites W1976609525 @default.
• W2092333630 cites W1983425499 @default.
• W2092333630 cites W1983435958 @default.
• W2092333630 cites W1985223881 @default.
• W2092333630 cites W1993674367 @default.
• W2092333630 cites W1994093302 @default.
• W2092333630 cites W1999407810 @default.
• W2092333630 cites W2003401347 @default.
• W2092333630 cites W2004445159 @default.
• W2092333630 cites W2017902760 @default.
• W2092333630 cites W2019025059 @default.
• W2092333630 cites W2028192160 @default.
• W2092333630 cites W2031348804 @default.
• W2092333630 cites W2033030430 @default.
• W2092333630 cites W2033331992 @default.
• W2092333630 cites W2034387660 @default.
• W2092333630 cites W2041404153 @default.
• W2092333630 cites W2045650652 @default.
• W2092333630 cites W2046135515 @default.
• W2092333630 cites W2050448984 @default.
• W2092333630 cites W2054144518 @default.
• W2092333630 cites W2055584145 @default.
• W2092333630 cites W2069393298 @default.
• W2092333630 cites W2072079883 @default.
• W2092333630 cites W2072830432 @default.
• W2092333630 cites W2088304371 @default.
• W2092333630 cites W2089736075 @default.
• W2092333630 cites W2105577106 @default.
• W2092333630 cites W2136180371 @default.
• W2092333630 cites W2162565570 @default.
• W2092333630 cites W9321131 @default.
• W2092333630 doi "https://doi.org/10.1016/j.pbb.2006.06.002" @default.
• W2092333630 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16828150" @default.
• W2092333630 hasPublicationYear "2006" @default.
• W2092333630 type Work @default.
• W2092333630 sameAs 2092333630 @default.
• W2092333630 citedByCount "14" @default.
• W2092333630 countsByYear W20923336302012 @default.
• W2092333630 countsByYear W20923336302013 @default.
• W2092333630 countsByYear W20923336302016 @default.
• W2092333630 countsByYear W20923336302017 @default.
• W2092333630 countsByYear W20923336302018 @default.
• W2092333630 countsByYear W20923336302020 @default.
• W2092333630 crossrefType "journal-article" @default.
• W2092333630 hasAuthorship W2092333630A5010653984 @default.
• W2092333630 hasAuthorship W2092333630A5036789705 @default.
• W2092333630 hasAuthorship W2092333630A5088427667 @default.
• W2092333630 hasConcept C126322002 @default.
• W2092333630 hasConcept C134018914 @default.
• W2092333630 hasConcept C137183658 @default.
• W2092333630 hasConcept C170493617 @default.
• W2092333630 hasConcept C185592680 @default.
• W2092333630 hasConcept C2775864247 @default.
• W2092333630 hasConcept C2776552330 @default.
• W2092333630 hasConcept C2776885963 @default.
• W2092333630 hasConcept C2777397205 @default.
• W2092333630 hasConcept C2778122271 @default.
• W2092333630 hasConcept C2778938600 @default.
• W2092333630 hasConcept C2780204788 @default.
• W2092333630 hasConcept C2780948874 @default.
• W2092333630 hasConcept C42219234 @default.
• W2092333630 hasConcept C50156730 @default.
• W2092333630 hasConcept C513476851 @default.
• W2092333630 hasConcept C53910766 @default.
• W2092333630 hasConcept C71924100 @default.
• W2092333630 hasConcept C98274493 @default.
• W2092333630 hasConceptScore W2092333630C126322002 @default.
• W2092333630 hasConceptScore W2092333630C134018914 @default.
• W2092333630 hasConceptScore W2092333630C137183658 @default.
• W2092333630 hasConceptScore W2092333630C170493617 @default.
• W2092333630 hasConceptScore W2092333630C185592680 @default.
• W2092333630 hasConceptScore W2092333630C2775864247 @default.
• W2092333630 hasConceptScore W2092333630C2776552330 @default.
• W2092333630 hasConceptScore W2092333630C2776885963 @default.
• W2092333630 hasConceptScore W2092333630C2777397205 @default.
• W2092333630 hasConceptScore W2092333630C2778122271 @default.
• W2092333630 hasConceptScore W2092333630C2778938600 @default.
• W2092333630 hasConceptScore W2092333630C2780204788 @default.
• W2092333630 hasConceptScore W2092333630C2780948874 @default.
• W2092333630 hasConceptScore W2092333630C42219234 @default.
• W2092333630 hasConceptScore W2092333630C50156730 @default.
• W2092333630 hasConceptScore W2092333630C513476851 @default.
• W2092333630 hasConceptScore W2092333630C53910766 @default.
• W2092333630 hasConceptScore W2092333630C71924100 @default.
• W2092333630 hasConceptScore W2092333630C98274493 @default.
• W2092333630 hasIssue "2" @default.

• next